The Years Before the Number Moves.
The training holds. The food is reasonable. The annual physical comes back normal. And still the body is not cooperating the way it used to — and you are not imagining it.
Send My Free White PaperNormal Is Where We Start Looking, Not Where We Stop
Across U.S. adults measured on the full cardiometabolic picture, only 6.8% met the criteria for optimal health (O’Hearn et al., JACC, 2022, NHANES n=55,081).
Being metabolically off while doing everything right is the statistical norm, not the exception. Metabolic syndrome prevalence rose to 41.8% in 2017–2018 (Liang et al., Postgraduate Medical Journal, 2023, NHANES 2011–18, n=8,183).
Insulin sensitivity begins its steep decline about five years before diagnosis while fasting glucose only rises sharply from about three.
The gap between those two trajectories is the window a standard glucose test reads clean (Tabák et al., Lancet, 2009, Whitehall II, n=6,538).
There is no reliable read of metabolic health in the scale or the BMI built on it. Up to about 30% of adults classed obese by BMI are metabolically healthy.
A substantial share of normal-weight adults are not. Two people at the same weight can sit on opposite sides of metabolic risk (Engin, Adv Exp Med Biol, 2017). The scale is a poor proxy for what is actually happening underneath it, and none of the drivers behind the change appear on a standard panel.
What This White Paper Will Show You
Written for the person between 40 and 65 who is doing everything right and watching the same effort return a different result.
Why this is measurable years before a diagnosis — and why a clean fasting glucose does not rule it out.
The measurable drivers behind the change — fasting insulin and HOMA-IR, glucose regulation in context, visceral adiposity, lipid particle detail, and muscle status.
What a physician-led read measures that the annual physical skips — read against optimal ranges, not disease cut-offs, and never a self-assigned diagnosis.
Where the Evidence Stops
Every claim in this paper ships with its limit attached. Here are the four limits.
A driver panel is not a diabetes diagnosis.
A driver panel characterises metabolic function; it does not diagnose disease. Insulin resistance is not a diagnosis and HOMA-IR is a risk-prediction threshold. Reading either one as a diabetes diagnosis would be factually wrong.
A single number does not carry the picture.
No one marker carries the picture, and the scale and BMI misread it in both directions (Engin, 2017). A single figure read alone tells you nothing you did not already know. The useful measurement is the driver panel.
Moving a marker has not been shown to change an outcome.
Structured resistance and impact training improved physical function and body composition in older adults with obesity (Mesinovic et al., 2025, n=49). That is what was measured — function and body composition, not a hard outcome — and we will say which one applies to you.
Measurement, not a product.
Nothing here is a product. What is on offer is measurement read by a physician against your own history. Pricing is discussed at the consultation, not on this page. We test first. Therapy only when indicated.
See what the standard panel does not.
The free white paper on why normal blood sugar can hide years of metabolic change, what actually drives it, and what a physician-led read looks at instead of any of it.
- Why this is measurable years before a diagnosis is made
- The measurable drivers behind the change
- What a physician-led read measures that the annual physical skips
Where should we send your white paper?
Educational, not medical advice · No spam, ever · Unsubscribe anytime · Your information is never shared.